In contrast, Fei Lee et al. published a study demonstrating that PARP4 deficiency or mutation promotes progression and malignancy in KRAS- and EGFR-driven lung cancer cells through a direct association with hnRNPM, a key protein controlling circRNA biogenesis, stability, and splicing fidelity [53]. Here, PARP4 is linked to lung carcinoma.